Prosthetic Joint Infection Clinical Trial
— Bac-UPOfficial title:
Bacteriological Setting Before Prosthesis Implantation With One Stage Surgery in Prosthetic Joint Infection
Verified date | July 2018 |
Source | Groupe Hospitalier Diaconesses Croix Saint-Simon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic prosthetic joint infection (PJI) is a devastating complication of arthroplasty and
its treatment continues to fuel the debate on how to manage it appropriately.
One stage and two stage exchange surgery both are the conventional surgical procedures for
chronic PJI commonly used to date.
Two stage surgery disadvantages (major surgery, anesthesia and nosocomial risks, functional
impairment between surgeries and a high socio-economic coast) encouraged many surgical teams
to adopt one stage exchange surgery which provides equivalent or better outcomes. However one
stage surgery encounters a major conceptual difficulty when it comes to implant the new
prosthesis in a surgical site microbiologically undetermined and potentially contaminated.
Investigators suppose the new prosthesis is implanted in a contaminated setting regardless of
bacteria type and antibiotic therapy duration before arthroplasty.
The total lack of data answering this question motivated the conception of this prospective
study in order to describe the microbiological setting where is implanted the new prosthesis
with one stage exchange surgery after surgical excision and antibiotic therapy initiation in
chronic PJI.
Status | Completed |
Enrollment | 100 |
Est. completion date | June 2018 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient consent - Aged over 18 years - PJI documented preoperatively by joint fluid culture according to Musculoskeletal Infection Society Definition - Monoarticular PJI - PJI management validated at the weekly cross-disciplinary conciliation meeting - PJI treated with one stage surgery and intravenous antibiotherapy adjusted to preoperative aspiration results. Exclusion Criteria: - patient who does not meet eligibility criteria - Negative preoperative aspiration culture - PJI du to fungi - Patient lawfully deprived of his liberty - Patient insured under social security scheme |
Country | Name | City | State |
---|---|---|---|
France | Groupe Hospitalier Diaconesses Croix Saint Simon | Paris | Ile De France |
Lead Sponsor | Collaborator |
---|---|
Groupe Hospitalier Diaconesses Croix Saint-Simon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The number of patients with positive per-operative sample culture after surgical excision and antibiotic initiation and prior prosthesis implantation | In routine care procedure for prosthetic joint infection (PJI), at least, five intraoperative samples are taken before debridement and prosthesis removal in order to identify the causative organism. For the purpose of this study three additional intraoperative samples will be performed after debridement and antibiotic initiation and prior prosthesis implantation. | 18 months | |
Secondary | Description of microbiological evolution of preoperative and perioperative samples before and after surgical excision. | In routine care procedure for prosthetic joint infection (PJI), at least, five intraoperative samples are taken before debridement and prosthesis removal in order to identify the causative organism. For the purpose of this study three additional intraoperative samples will be performed after debridement and antibiotic initiation and prior prosthesis implantation. | 18 months | |
Secondary | Description of outcomes of perioperative sample culture after surgical excision according to the identified germ in culture before excision. | In routine care procedure for prosthetic joint infection (PJI), at least, five intraoperative samples are taken before debridement and prosthesis removal in order to identify the causative organism. For the purpose of this study three additional intraoperative samples will be performed after debridement and antibiotic initiation and prior prosthesis implantation. | 18 months | |
Secondary | Description of outcomes of perioperative sample culture after surgical excision according to antibiotherapy duration from initiation until perioperative samples. | In routine care procedure for prosthetic joint infection (PJI), at least, five intraoperative samples are taken before debridement and prosthesis removal in order to identify the causative organism. For the purpose of this study three additional intraoperative samples will be performed after debridement and antibiotic initiation and prior prosthesis implantation. | 18 months | |
Secondary | Description of outcomes of perioperative sample culture prior surgical excision in patients treated with preoperative antibiotherapy. | In routine care procedure for prosthetic joint infection (PJI), at least, five intraoperative samples are taken before debridement and prosthesis removal in order to identify the causative organism. For the purpose of this study three additional intraoperative samples will be performed after debridement and antibiotic initiation and prior prosthesis implantation. | 18 months | |
Secondary | Description of outcomes of perioperative sample culture according to symptoms duration prior surgery. | In routine care procedure for prosthetic joint infection (PJI), at least, five intraoperative samples are taken before debridement and prosthesis removal in order to identify the causative organism. For the purpose of this study three additional intraoperative samples will be performed after debridement and antibiotic initiation and prior prosthesis implantation. | 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04067843 -
Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study
|
N/A | |
Enrolling by invitation |
NCT05247281 -
NGS vs Culture Outcomes for Treatment of PJI
|
N/A | |
Withdrawn |
NCT05269121 -
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
|
Phase 1/Phase 2 | |
Recruiting |
NCT02801253 -
Cohort of Prosthetic Joint Infections
|
||
Completed |
NCT03694925 -
Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Revision Total Knee Arthroplasty
|
||
Completed |
NCT03721328 -
Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation
|
Phase 2 | |
Withdrawn |
NCT04787250 -
Bacteriophage Therapy in Patients With Prosthetic Joint Infections
|
Phase 1/Phase 2 | |
Recruiting |
NCT03307109 -
Quality of Life in Patients Having a Prosthetic Joint Infection
|
||
Recruiting |
NCT04661345 -
Identification of Molecular Marker of Coagulase-negative Staphylococci for the Diagnosis of Prosthetic Joint Infections
|
||
Recruiting |
NCT02805803 -
Quality of Life Assessment in Patients Undergoing Prolonged Suppressive Antibiotherapy for Prosthetic Joint Infection.
|
N/A | |
Completed |
NCT02413034 -
The Influence of Antibiotic Prophylaxis on Intraoperative Prosthetic Joint Infection Cultures
|
N/A | |
Recruiting |
NCT03784807 -
New Strategies for Biofilm Related Infections
|
||
Completed |
NCT04662632 -
Abbreviated Protocol for Two-Stage Exchange
|
Phase 2 | |
Not yet recruiting |
NCT04390607 -
Leukocyte Esterase Sensor Test
|
||
Recruiting |
NCT04650607 -
Phage Safety Cohort Study
|
||
Active, not recruiting |
NCT04946500 -
Clindamycin in Prosthetic Joint Infections Caused by Staphylococcus (CISTA)
|
||
Recruiting |
NCT04762706 -
Measuring Distress in Prosthetic Joint Infection Using a Standardized Metric: CRUTCH Pathway Pilot.
|
N/A | |
Withdrawn |
NCT05269134 -
Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
|
Phase 2 | |
Not yet recruiting |
NCT05239312 -
Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital
|
||
Completed |
NCT04294862 -
Tissue Distribution, Pharmacokinetics, Safety, and Tolerability After a Single Dose of TNP-2092 in Participants Undergoing Primary Total Hip or Knee Arthroplasty
|
Phase 1 |